Ohio State Navbar

Study Identifies Possible Target For Future Brain Cancer Drugs


  A molecule in cells that shuts down the expression of genes might be a promising target for new  
  drugs   designed to treat the most frequent and lethal form of brain cancer, according to a  
  new study
 by researchers at the OSUCCC – James. The findings were published in the
  journal Cancer
 Research. Robert Baiocchi, MD, PhD, associate professor of medicine at Ohio
  State and a hematologist at the OSUCCC – James, was co-corresponding author. Read more: